Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1984 Aug;37(8):867–869. doi: 10.1136/jcp.37.8.867

Maternal serum alpha 1-antitrypsin concentrations in normotensive and hypertensive pregnancies.

M Legge, G B Duff, H C Potter, M M Hoetjes
PMCID: PMC498883  PMID: 6332123

Abstract

Maternal serum alpha 1-antitrypsin concentrations were measured serially in pregnant women who were normotensive and those with mild, moderate, and severe hypertension of pregnancy from 27 weeks' gestation to term. alpha 1-antitrypsin concentrations increased with advancing gestation in all four groups. In addition, the hypertensive pregnancies showed higher than normal concentrations at each stage of pregnancy, with values in the severe hypertension group being higher than values in the other two hypertensive groups. At 35-36 weeks' gestation to term the increase in alpha 1-antitrypsin in the severe hypertension group was significant (p less than 0.05) when compared with the normotensive group. Although plasma oestriol and progesterone concentrations increased with advancing gestation in all groups, there was no direct relation between their concentrations and the increase in alpha 1-antitrypsin concentration in the hypertensive groups.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATTWOOD H. D., PARK W. W. Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonw. 1961 Aug;68:611–617. doi: 10.1111/j.1471-0528.1961.tb02778.x. [DOI] [PubMed] [Google Scholar]
  2. Aickin D. R., Duff G. B., Evans J. J., Legge M. Antenatal biochemical screening to predict low birthweight infants. Br J Obstet Gynaecol. 1983 Feb;90(2):129–133. doi: 10.1111/j.1471-0528.1983.tb08896.x. [DOI] [PubMed] [Google Scholar]
  3. Barbosa J., Seal U. S., Doe R. P. Effects of anabolic steroids on haptoglobin, orosomucoid, plasminogen, fibrinogen, transferrin, ceruloplasmin, alpha-1-antitrypsin, beta-glucuronidase and total serum proteins. J Clin Endocrinol Metab. 1971 Sep;33(3):388–398. doi: 10.1210/jcem-33-3-388. [DOI] [PubMed] [Google Scholar]
  4. Bhat A. R., Pattabiraman T. N. Comparative study of proteinase inhibitors in human amniotic fluid and maternal serum. Br J Obstet Gynaecol. 1980 Dec;87(12):1109–1114. doi: 10.1111/j.1471-0528.1980.tb04482.x. [DOI] [PubMed] [Google Scholar]
  5. Carr D. H. An experimental study of trophoblast growth in the lung. Obstet Gynecol. 1977 Oct;50(4):473–478. [PubMed] [Google Scholar]
  6. Duff G. B., Evans J. J., Legge M. A study of investigations used to predict outcome of pregnancy after threatened abortion. Br J Obstet Gynaecol. 1980 Mar;87(3):194–198. doi: 10.1111/j.1471-0528.1980.tb04517.x. [DOI] [PubMed] [Google Scholar]
  7. Ganrot P. O., Bjerre B. Alpha-1-antitrypsin and alpha-2-macroglobulin concentration in serum during pregnancy. Acta Obstet Gynecol Scand. 1967;46(2):126–137. [PubMed] [Google Scholar]
  8. Goodfellow C. F., Taylor P. V. Extraction and identification of trophoblast cells circulating in peripheral blood during pregnancy. Br J Obstet Gynaecol. 1982 Jan;89(1):65–68. doi: 10.1111/j.1471-0528.1982.tb04638.x. [DOI] [PubMed] [Google Scholar]
  9. Hercz A. The inhibition of proteinases by human alpha1-antitrypsin. Eur J Biochem. 1974 Nov 1;49(1):287–292. doi: 10.1111/j.1432-1033.1974.tb03833.x. [DOI] [PubMed] [Google Scholar]
  10. Jeppsson J. O., Laurell C. B., Nosslin B., Cox D. W. Catabolic rate of alpha1-antitrypsin of of Pi types S, and MMalton and of asialylated M-protein in man. Clin Sci Mol Med. 1978 Jul;55(1):103–107. doi: 10.1042/cs0550103. [DOI] [PubMed] [Google Scholar]
  11. Jämeri K. E., Koivuniemi A. P., Carpén E. O. Occurrence of trophoblasts in the blood of toxaemic patients. Gynaecologia. 1965;160(5):315–320. doi: 10.1159/000303403. [DOI] [PubMed] [Google Scholar]
  12. Kueppers F., Brackertz D., Czygan P. J. Serum 1 -antitrypsin levels during the ovarian cycle. Clin Chim Acta. 1972 Jun;39(1):131–134. doi: 10.1016/0009-8981(72)90308-7. [DOI] [PubMed] [Google Scholar]
  13. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  14. Laurell C. B., Kullander S., Thorell J. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins. Scand J Clin Lab Invest. 1968;21(4):337–343. doi: 10.3109/00365516809077003. [DOI] [PubMed] [Google Scholar]
  15. McKAY D. G., HERTIG A. T., ADAMS E. C., RICHARDSON M. V. Histochemical observations on the human placenta. Obstet Gynecol. 1958 Jul;12(1):1–36. doi: 10.1097/00006250-195807000-00001. [DOI] [PubMed] [Google Scholar]
  16. Ohlsson K., Laurell C. B. The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med. 1976 Jul;51(1):87–92. doi: 10.1042/cs0510087. [DOI] [PubMed] [Google Scholar]
  17. PARK W. W. Experimental trophoblastic embolism of the lungs. J Pathol Bacteriol. 1958 Apr;75(2):257–265. doi: 10.1002/path.1700750204. [DOI] [PubMed] [Google Scholar]
  18. Walker J. E., Campbell D. M., Ogston D. Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol. 1982 Mar;89(3):208–210. doi: 10.1111/j.1471-0528.1982.tb03615.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES